Trials / Completed
CompletedNCT01260168
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 435 (actual)
- Sponsor
- Exact Sciences Corporation · Industry
- Sex
- All
- Age
- 40 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to confirm the sensitivity of a stool DNA test for detection of colorectal cancer and pre-cancer. Another objective is to provide anonymous, clinically characterized specimens for a bio-repository for future colorectal cancer-related test development.
Detailed description
Patients who have been recently diagnosed with colo-rectal cancer or pre-cancer will be asked to submit a stool sample(s)(at least 7 days AFTER colonoscopy) and will have the option of submitting blood and tissue samples for future colo-rectal cancer-related test development.
Conditions
Timeline
- Start date
- 2010-10-01
- Primary completion
- 2013-11-01
- Completion
- 2013-11-01
- First posted
- 2010-12-15
- Last updated
- 2015-05-13
Locations
21 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT01260168. Inclusion in this directory is not an endorsement.